Evidence map›Paper›PMID 37277488›Full record

ArticleEuropean journal of human genetics : EJHG2024

Gustavson syndrome is caused by an in-frame deletion in RBMX associated with potentially disturbed SH3 domain interactions.

Josefin Johansson, Sarah Lidéus, Carina Frykholm, Cecilia Gunnarsson, Filip Mihalic, Sanna Gudmundsson, Sara Ekvall, Anna-Maja Molin, Mai Pham, Mauno Vihinen and 7 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Genetic Profiling of Polymicrogyria in a South Indian Cohort.Annals of Indian Academy of Neurology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Solving medical mysteries with genomics.European journal of human genetics : EJHG · 2024
    Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Josefin JohanssonDepartment of Immunology, Genetics and Pathology, Biomedical Centre, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-5152-4096
Sarah LidéusDepartment of Immunology, Genetics and Pathology, Biomedical Centre, Uppsala University, Uppsala, Sweden.
Carina FrykholmDepartment of Immunology, Genetics and Pathology, Biomedical Centre, Uppsala University, Uppsala, Sweden.
Cecilia GunnarssonDepartment of Clinical Genetics, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0001-9474-6820
Filip MihalicDepartment of Medical Biochemistry and Microbiology, Uppsala University, Box 582, Husargatan 3, 751 23, Uppsala, Sweden.ORCID 0000-0002-6840-2319
Sanna GudmundssonDepartment of Immunology, Genetics and Pathology, Biomedical Centre, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-2332-074X
Sara EkvallDepartment of Immunology, Genetics and Pathology, Biomedical Centre, Uppsala University, Uppsala, Sweden.
Anna-Maja MolinDepartment of Immunology, Genetics and Pathology, Biomedical Centre, Uppsala University, Uppsala, Sweden.
Mai PhamDepartment of Immunology, Genetics and Pathology, Biomedical Centre, Uppsala University, Uppsala, Sweden.
Mauno VihinenDepartment of Experimental Medical Science, BMC B13, Lund University, SE-22 184, Lund, Sweden.ORCID 0000-0002-9614-7976
Kristina Lagerstedt-RobinsonClinical Genetics, Karolinska University Hospital, Solna, Sweden.
Ann NordgrenClinical Genetics, Karolinska University Hospital, Solna, Sweden.
Per JemthDepartment of Medical Biochemistry and Microbiology, Uppsala University, Box 582, Husargatan 3, 751 23, Uppsala, Sweden.
Adam AmeurDepartment of Immunology, Genetics and Pathology, Biomedical Centre, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-6085-6749
Göran AnnerénDepartment of Immunology, Genetics and Pathology, Biomedical Centre, Uppsala University, Uppsala, Sweden.
Maria WilbeDepartment of Immunology, Genetics and Pathology, Biomedical Centre, Uppsala University, Uppsala, Sweden.
Marie-Louise BondesonDepartment of Immunology, Genetics and Pathology, Biomedical Centre, Uppsala University, Uppsala, Sweden. marielouise.bondeson@igp.uu.se.ORCID 0000-0002-3391-5341
Uppsala University · SEKarolinska University Hospital · SEBroad Institute · USLinköping University · SELund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA binding motif protein X-linked (RBMX) encodes the heterogeneous nuclear ribonucleoprotein G (hnRNP G) that regulates splicing, sister chromatid cohesion and genome stability. RBMX knock down experiments in various model organisms highlight the gene's importance for brain development. Deletion of the RGG/RG motif in hnRNP G has previously been associated with Shashi syndrome, however involvement of other hnRNP G domains in intellectual disability remain unknown. In the current study, we present the underlying genetic and molecular cause of Gustavson syndrome. Gustavson syndrome was first reported in 1993 in a large Swedish five-generation family presented with profound X-linked intellectual disability and an early death. Extensive genomic analyses of the family revealed hemizygosity for a novel in-frame deletion in RBMX in affected individuals (NM_002139.4; c.484_486del, p.(Pro162del)). Carrier females were asymptomatic and presented with skewed X-chromosome inactivation, indicating silencing of the pathogenic allele. Affected individuals presented minor phenotypic overlap with Shashi syndrome, indicating a different disease-causing mechanism. Investigation of the variant effect in a neuronal cell line (SH-SY5Y) revealed differentially expressed genes enriched for transcription factors involved in RNA polymerase II transcription. Prediction tools and a fluorescence polarization assay imply a novel SH3-binding motif of hnRNP G, and potentially a reduced affinity to SH3 domains caused by the deletion. In conclusion, we present a novel in-frame deletion in RBMX segregating with Gustavson syndrome, leading to disturbed RNA polymerase II transcription, and potentially reduced SH3 binding. The results indicate that disruption of different protein domains affects the severity of RBMX-associated intellectual disabilities.

Indexed as

DeafnessIntellectual DisabilityNeuroblastomaOptic AtrophySeizuresX-Linked Intellectual DisabilityFemaleHeterogeneous-Nuclear RibonucleoproteinsHumansRNA-Binding ProteinsRNA Polymerase IIsrc Homology DomainsHeterogeneous-Nuclear RibonucleoproteinsRBMX protein, humanRNA-Binding ProteinsRNA Polymerase II

Identifiers

PMID37277488
PMCPMC10923852
OpenAlexW4379468110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.